ABSTRACT
In this paper, a thorough investigation is presented on the static and dynamic behaviors of a short-span cable-stayed bridge (CSB) incorporating steel and carbon fiber reinforced polymer (CFRP) hybrid cables. The study focuses on the world's largest span and China's first highway, CFRP CSB. The performance of the CSB was compared using numerical simulations under four different cable patterns: steel cables, CFRP cables, and steel, and two types of hybrid cables with different structural arrangements. The results indicate that the use of the use of CFRP cables in the long cable region in the short-span CSB project investigated in this study offers improved performance in terms of stability, seismic response, and reduced displacements. In comparison to CFRP cables, hybrid cables have demonstrated a reduction of 12% in the maximum vertical displacement of the main girder. On the other hand, the hybrid cables result in reduced maximum internal forces and longitudinal and lateral displacements of the main girders and towers compared to steel cables. The difference in the arrangement of CFRP cables in the long cable region or short cable region is not obvious under dead loads, but significant differences still exist between the CFRP cable bridges in the short cable region and the long cable region in terms of live load effects, temperature effects, and dynamic characteristics.
ABSTRACT
Osteosarcoma (OS) is one of the most primary bone malignancies, often occurring in adolescents or children. Numerous scientific findings have introduced that long noncoding RNAs (lncRNAs) can be involved in tumor occurrence and development. Although DSCAM-AS1 has been studied in several cancers, its role and mechanism in OS are poorly understood. In this work, high level of DSCAM-AS1 was validated in OS cell lines. Depleting DSCAM-AS1 inhibited cell proliferation, migration and EMT process in OS. Subsequently, we disclosed that DSCAM-AS1 was mainly observed in the cytoplasm of OS cells and could bind with miR-186-5p in OS. Moreover, inhibiting miR-186-5p rescued the impact of silenced DSCAM-AS1 on OS progression. Additionally, GPRC5A was verified as the target downstream of miR-186-5p, and it was negatively modulated by miR-186-5p but positively regulated by DSCAM-AS1. More importantly, DSCAM-AS1 enhanced GPRC5A level in OS by sequestering miR-186-5p. Finally, up-regulating GPRC5A reversed the influences of DSCAM-AS1 repression on the oncogenic behaviors of OS cells. Knockdown of DSCAM-AS1 suppressed NPC tumor growth in vivo. All findings uncovered that DSCAM-AS1 aggravated OS progression through sponging miR-186-5p to up-regulate GPRC5A expression. Thus, we proposed DSCAM-AS1 as a probable target for OS treatment.
